Skip to content
Clinical Trials – home
IrelandBack to Ireland

Clinical trials in Cork – page 6

159 clinical trials in Cork, Ireland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Cork at a glance
159
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

159 trials in Cork

Open in trial search

Arteriosclerosis

Not yet recruiting

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Malignant peritoneal neoplasm+2

Not yet recruiting

Azenosertib versus drug combination in platinum‑resistant high‑grade serous ovarian, fallopian tube or primary peritoneal cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Azenosertib
  • Sponsor:K-Group Beta Inc.

Cystic fibrosis

Not yet recruiting

Safety and Efficacy of VX-828, Deutivacaftor, and Tezacaftor in Adults with Cystic Fibrosis

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Sponsor:Vertex Pharmaceuticals Inc.

Hereditary haemochromatosis

Not yet recruiting

A study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Vamifeport trihydrochloride
  • Sponsor:CSL Behring LLC

Glioblastoma

Not yet recruiting

Phase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Neurotrials LLC

Study of intravenous melatonin safety and dosing in newborns with moderate to severe hypoxic-ischaemic encephalopathy receiving therapeutic hypothermia treatment

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Melatonin
  • Sponsor:University College London

Fallopian tube cancer+1

Not yet recruiting

Study of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Glatiramer Acetate
  • Sponsor:Torl Biotherapeutics LLC

Neoplasm malignant

Not yet recruiting

Study on the Effectiveness and Safety of Luveltamab Tazevibulin Compared to Chemotherapy in Women with Relapsed Platinum-resistant Ovarian Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Sutro Biopharma Inc.

Fallopian tube cancer+1

Not yet recruiting

Study of Mirvetuximab Soravtansine and Bevacizumab for Maintenance in Adults with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Breast cancer

Not yet recruiting

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Eli Lilly & Co.

Acute myeloid leukaemia

Not yet recruiting

Study on the Safety of Ivosidenib and Azacitidine for Adults with Newly Diagnosed IDH1m Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Servier Affaires Medicales

Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Cork

What the registry says about research in the country

01 Oncology Research

Extensive clinical trials focusing on lung cancer treatments, including innovative therapies for non-small cell lung cancer and testing new drug combinations. Studies evaluating treatments for breast cancer, particularly in hormone receptor-positive and HER2-negative variants.

  • Advanced Lung Cancer Treatments
  • Breast Cancer Therapies
  • Prostate Cancer Studies

Multiple trials exploring combination therapies and novel treatment approaches for various cancer types.

02 Hematologic Disorders

Research initiatives examining treatments for chronic lymphocytic leukemia and lymphomas. Studies evaluating new therapeutic approaches for myelodysplastic syndromes, focusing on reducing transfusion dependency.

  • Leukemia Treatments
  • Lymphoma Therapies
  • Blood Disorders Management

Innovative approaches combining multiple therapeutic agents to improve patient outcomes.

03 Autoimmune Conditions

Clinical studies investigating treatments for Primary Sjögren's Disease and atopic dermatitis. Research on novel therapeutic approaches for inflammatory conditions and immune system disorders.

  • Inflammatory Disease Treatments
  • Skin Condition Therapies
  • Immune System Modulation

Focus on developing targeted therapies to improve patient quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.